Craifロゴ
About
ドロップダウンアイコン
Our Science
ドロップダウンアイコン
News & Media
ドロップダウンアイコン
Careers
Contact Us
JP
/
EN
Craifロゴ
メニューアイコン
News & Media
Research
Research
Craif’s Urinary MicroRNA Study Demonstrates Early Detection, Prognostic Stratification, and Lung Cancer Recurrence Monitoring, Published in npj Precision Oncology
2026.04.30
Research
Craif Presents Collaborative Research on Urinary MicroRNA-Based Early Detection and Prognostic Stratification in Lung Cancer at the AACR Annual Meeting 2026
2026.04.30
Research
Cancer Signals Reach Urine, Often at Higher Concentrations Than Blood: Study Identifies the Mechanism for the First Time
2026.02.24
Research
Urinary MicroRNA and AI Separated Pancreatic Cancer from High-Risk Patients with an AUC of 0.89
2026.01.28
Research
Craif Multicenter Study Reports AUC 0.85 for Urinary MicroRNA and AI Detection of Esophageal Cancer
2026.01.21
Research
Craif Urine microRNA Aging Clock Estimates Biological Age to Within 4.4 Years on Average in 6,331 People
2026.01.16
Research
Urinary MicroRNA Distinguished Immune Checkpoint Inhibitor Responders From Non-Responders in a 12 Patient Urothelial Carcinoma Study
2025.08.27
Research
miSignal Scan Wins Two Awards in the Tokyo Metropolitan Government's Fiscal 2024 Venture Technology Grand Prize
2024.11.21
Research
Urinary MicroRNA Assay Detected Stage I and IIA Pancreatic Cancer at 92.9 Percent Sensitivity, Against 37.5 Percent for the Blood Marker CA19-9
2024.11.18
Research
Craif Starts an 800-Participant Multicenter Clinical Trial of a Software Medical Device Intended to Aid Pancreatic Cancer Diagnosis From Urinary MicroRNA
2024.10.30
1
2
3
4
Last
Recruitment
arrowarrow
Information about recruitment